{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:03:29Z","timestamp":1789833809851,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006264","name":"RIKEN","doi-asserted-by":"publisher","award":["Incentive Research Projects grant"],"award-info":[{"award-number":["Incentive Research Projects grant"]}],"id":[{"id":"10.13039\/501100006264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.micpath.2026.108786","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:09:11Z","timestamp":1787209751000},"page":"108786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In vitro antiviral effects of an mTORC1 inhibitor targeting the rapamycin-binding protein complex"],"prefix":"10.1016","volume":"220","author":[{"given":"Takafumi","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8408-2622","authenticated-orcid":false,"given":"Sonoko","family":"Watanuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0026-3888","authenticated-orcid":false,"given":"Yasunobu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-9784","authenticated-orcid":false,"given":"Hideyuki","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7400-3587","authenticated-orcid":false,"given":"Yoko","family":"Aida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6232","key":"10.1016\/j.micpath.2026.108786_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.micpath.2026.108786_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1515\/jtim-2017-0007","article-title":"Direct acting anti-hepatitis C virus drugs: clinical pharmacology and future direction","volume":"5","author":"Geddawy","year":"2017","journal-title":"Journal of translational internal medicine"},{"key":"10.1016\/j.micpath.2026.108786_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies in respiratory viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.micpath.2026.108786_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"7448","key":"10.1016\/j.micpath.2026.108786_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"Yang","year":"2013","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.micpath.2026.108786_bib6","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1101\/gad.912401","article-title":"Hierarchical phosphorylation of the translation inhibitor 4E-BP1","volume":"15","author":"Gingras","year":"2001","journal-title":"Gene Dev."},{"issue":"45","key":"10.1016\/j.micpath.2026.108786_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.micpath.2026.108786_bib8","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1074\/jbc.M900301200","article-title":"An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1","volume":"284","author":"Thoreen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.micpath.2026.108786_bib9","doi-asserted-by":"crossref","first-page":"14194","DOI":"10.1073\/pnas.0606109103","article-title":"Influenza A virus NS1 protein binds p85\u03b2 and activates phosphatidylinositol-3-kinase signaling","volume":"103","author":"Hale","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6508","key":"10.1016\/j.micpath.2026.108786_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1126\/science.abc8665","article-title":"Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2","volume":"369","author":"Thoms","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.micpath.2026.108786_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108786_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1021\/acs.jmedchem.2c01658","article-title":"Discovery of RMC-5552, a selective bi-steric inhibitor of mTORC1, for the treatment of mTORC1-activated tumors","volume":"66","author":"Burnett","year":"2022","journal-title":"J. Med. Chem."},{"issue":"7606","key":"10.1016\/j.micpath.2026.108786_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature17963","article-title":"Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor","volume":"534","author":"Rodrik-Outmezguine","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.micpath.2026.108786_bib14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1021\/acs.jmedchem.1c00536","article-title":"In silico and in cell hybrid selection of Nonrapalog ligands to allosterically inhibit the kinase activity of mTORC1","volume":"65","author":"Shams","year":"2022","journal-title":"J. Med. Chem."},{"issue":"5254","key":"10.1016\/j.micpath.2026.108786_bib15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/227168a0","article-title":"Characteristics of a human diploid cell designated MRC-5","volume":"227","author":"Jacobs","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108786_bib16","first-page":"264","article-title":"Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium","volume":"12","author":"Gey","year":"1952","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.micpath.2026.108786_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0092-8674(81)90282-8","article-title":"SV40-transformed simian cells support the replication of early SV40 mutants","volume":"23","author":"Gluzman","year":"1981","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.micpath.2026.108786_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3181\/00379727-98-24111","article-title":"Established kidney cell lines of normal adult bovine and ovine origin","volume":"98","author":"Madin","year":"1958","journal-title":"PSEBM (Proc. Soc. Exp. Biol. Med.)"},{"key":"10.1016\/j.micpath.2026.108786_bib19","series-title":"A Simple Method of Estimating Fifty per Cent Endpoints","author":"Reed","year":"1938"},{"issue":"8","key":"10.1016\/j.micpath.2026.108786_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1073\/pnas.38.8.747","article-title":"Production of plaques in monolayer tissue cultures by single particles of an animal virus","volume":"38","author":"Dulbecco","year":"1952","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2026.108786_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1039\/a809656b","article-title":"A water-soluble tetrazolium salt useful for colorimetric cell viability assay","volume":"36","author":"Tominaga","year":"1999","journal-title":"Anal. Commun."},{"issue":"2","key":"10.1016\/j.micpath.2026.108786_bib22","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.03659-14","article-title":"Antiviral potential of ERK\/MAPK and PI3K\/AKT\/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis","volume":"59","author":"Kindrachuk","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2026.108786_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/v13020354","article-title":"Resveratrol inhibits HCoV-229E and SARS-CoV-2 coronavirus replication in vitro","volume":"13","author":"Pasquereau","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2026.108786_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ebiom.2018.05.027","article-title":"Comprehending a killer: the Akt\/mTOR signaling pathways are temporally high-jacked by the highly pathogenic 1918 influenza virus","volume":"32","author":"Ranadheera","year":"2018","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.micpath.2026.108786_bib25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41564-021-00958-0","article-title":"Cellular host factors for SARS-CoV-2 infection","volume":"6","author":"Baggen","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.micpath.2026.108786_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108051","article-title":"Endolysosomes as a sorting hub for emerging viruses: gatekeepers of cellular defense, viral fate and promising therapeutic target","volume":"222","author":"Post","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.micpath.2026.108786_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12931-017-0618-6","article-title":"Sirolimus alters lung pathology and viral load following influenza A virus infection","volume":"18","author":"Alsuwaidi","year":"2017","journal-title":"Respir. Res."},{"issue":"7","key":"10.1016\/j.micpath.2026.108786_bib28","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/bph.70258","article-title":"Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir","volume":"183","author":"Zamzamy","year":"2026","journal-title":"Br. J. Pharmacol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026005127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:20:32Z","timestamp":1789831232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026005127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"alternative-id":["S0882401026005127"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108786","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antiviral effects of an mTORC1 inhibitor targeting the rapamycin-binding protein complex","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108786"}}